Fig. 4From: Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reportsComparison of the proposed method with MGPS on newly approved drugs: a yearly rankings change of Liraglutide-Renal failure, and the label change happens in 2011, b yearly rankings change of Pazopanib-Impaired wound healing, and the label change happens in 2014Back to article page